Time Trend of the Sensitivity of the Pneumococcal Urinary Antigen Test for Diagnosing Pneumococcal Community-Acquired Pneumonia: An Analysis of 15-Year, Prospective Cohort Data
Open Access
- 2 August 2021
- journal article
- research article
- Published by Springer Nature in Infectious Diseases and Therapy
- Vol. 10 (4) , 2309-2322
Abstract
Introduction Whether the sensitivity of the BinaxNOW Streptococcus pneumoniae urinary antigen test kit (BinaxNOW), adjusted by some variables including vital signs, laboratory examinations and pneumonia severity, has been decreasing is unknown. The aim of the present study was to investigate whether BinaxNOW sensitivity has decreased recently and to identify the predictors of the BinaxNOW result, including the time trend. Methods This prospective cohort study enrolled consecutive patients with pneumococcal community-acquired pneumonia who were hospitalised at Kurashiki Central Hospital from January 2001 to December 2015. Pneumococcal community-acquired pneumonia was defined as positive blood or pleural effusion or sputum culture results. To evaluate the effect of the time trend for the sensitivity of BinaxNOW, time series regression analysis was performed. In addition, predictors of the BinaxNOW result were examined by multivariable analysis using variables such as sex, vital signs, blood tests such as C-reactive protein, albumin, blood urea nitrogen, creatinine, white blood cell count, haematocrit and platelets, antibiotic pre-treatment, bacteraemia, and pneumonia severity, in addition to time trend and seasonality. Results A total of 446 patients were included. BinaxNOW sensitivity showed a significant, gradual decrease from 2001 (81.3%) to 2015 (48.7%). On multivariable analysis [odds ratio (95% confidence interval)], bacteraemia [2.516 (1.387–4.561), P = 0.002] was a predictor of a positive BinaxNOW result, whereas male sex [0.467 (0.296–0.736), P = 0.001], white blood cell count [0.959 (0.930–0.989), P = 0.008] and the time trend per year [0.900 (0.859–0.943), P < 0.001] were predictors of a negative BinaxNOW result. Conclusions The sensitivity of BinaxNOW decreased over a 15-year period. We should be careful when interpreting BinaxNOW results in daily clinical practice, and the development of a new kit with good sensitivity is anticipated. Trial registration number UMIN000004353.Keywords
This publication has 40 references indexed in Scilit:
- Interpreting Assays for the Detection of Streptococcus pneumoniaeClinical Infectious Diseases, 2011
- Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in JapanEpidemiology and Infection, 2009
- Evaluation of a Rapid Immunochromatographic ODK0501 Assay for Detecting Streptococcus pneumoniae Antigen in Sputum Samples from Patients with Lower Respiratory Tract InfectionClinical and Vaccine Immunology, 2009
- A novel method for rapid detection of Streptococcus pneumoniae antigen in sputum and its application in adult respiratory tract infectionsJournal of Medical Microbiology, 2008
- Laboratory Diagnosis of Invasive Pneumococcal DiseaseClinical Infectious Diseases, 2008
- Performance of a Pneumolysin Enzyme-Linked Immunosorbent Assay for Diagnosis of Pneumococcal InfectionsJournal of Clinical Microbiology, 2007
- Rapid diagnosis of pneumococcal pneumonia among HIV-infected adults with urine antigen detectionJournal of Infection, 2007
- A simple prediction algorithm for bacteraemia in patients with acute febrile illnessQJM: An International Journal of Medicine, 2005
- Comparison of Two Urinary Antigen Tests for Establishment of Pneumococcal Etiology of Adult Community-Acquired PneumoniaJournal of Clinical Microbiology, 2004
- Evaluation of a Rapid Immunochromatographic Test for Detection of Streptococcus pneumoniae Antigen in Urine Samples from Adults with Community-Acquired PneumoniaJournal of Clinical Microbiology, 2001